Collegium Doubles Its ADHD Portfolio By Snagging Corium Drug

 
• By Joseph Haas
  
ADHD
With $650m upfront payment, Collegium now has two ADHD drugs to market • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business